Toshihide Nakada

458 citations
9 papers · 370 indexed · h-index 6
Topics
Pregnancy and preeclampsia studies (2 papers)Pluripotent Stem Cells Research (2 papers)Telomeres, Telomerase, and Senescence (2 papers)
Partner nations
JapanUnited States

In The Last Decade

Toshihide Nakada

9 papers receiving 361 citations

Peers

Toshihide Nakada
Comparison fields: 5 of 67
  • Molecular Biology 152
  • Cancer Research 138
  • Physiology 97
  • Oncology 71
  • Immunology 62
Replace Shigenori Furukawa with:
Shigenori Furukawa Japan
Alireza Heravi‐Moussavi Canada
K. Oliva Australia
Weizhi Xue China
Wei Cang China
Kanwal Minhas Canada
Ashley N. Kamimae-Lanning United States
Sven Ackermann Germany
Eva Galle Belgium
Chung‐Tai Yue Taiwan
Toshihide Nakada relative to Shigenori Furukawa Japan Shigenori Furukawa's profile →
Citations per field
00.5×4.4×
Shigenori Furukawa · 1×
Citations per year

Countries citing papers authored by Toshihide Nakada

Since Specialization
Citations

This map shows the geographic impact of Toshihide Nakada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshihide Nakada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshihide Nakada more than expected).

Fields of papers citing papers by Toshihide Nakada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshihide Nakada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshihide Nakada. The network helps show where Toshihide Nakada may publish in the future.

Co-authorship network of co-authors of Toshihide Nakada

This figure shows the co-authorship network connecting the top 25 collaborators of Toshihide Nakada. A scholar is included among the top collaborators of Toshihide Nakada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshihide Nakada. Toshihide Nakada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 3
2 164
3 75
4 14
5 5
6 45
7 3
8 7
9
Inhibition by dexamethasone of human neutrophil apoptosis in vitro.
54

About Toshihide Nakada

Toshihide Nakada is a scholar working on Obstetrics and Gynecology, Immunology and Allergy and Nephrology, having authored 9 papers that have together received 370 indexed citations. Recurring topics across this work include Pregnancy and preeclampsia studies (2 papers), Pluripotent Stem Cells Research (2 papers) and Telomeres, Telomerase, and Senescence (2 papers). The work is most often cited by research in Cancer Research (138 citations), Obstetrics and Gynecology (58 citations) and Aging (7 citations). Toshihide Nakada has collaborated with scholars based in Japan and United States. Frequent co-authors include Hirotaka Nishi, Keiichi Isaka, Jerry W. Shay, Masaki Inoue, Satoru Kyo, Tomoyuki Kato, Fujiro Sendo, Y. Takeda, Eric Huang and Masaomi Takayama. Their work appears in journals such as Molecular and Cellular Biology, Cancer and Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026